Influenza Vaccine Randomized Educational Trial: Adult

Overview

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate patients, public health entities and physicians give informational handouts in various forms.

However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. The purpose of this study is to compare the effectiveness of pro-vaccine messages of local data, pro-vaccine messages of national data, and no educational message on patient's receipt of the influenza vaccine. These results will help to understand the relationship between patient education and the intent to vaccinate and receipt of the influenza vaccine as well as to optimize educational information given to patients regarding the influenza vaccine.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: May 31, 2017

Interventions

  • Behavioral: Local educational information
    • Adult patients in this arm receive educational information regarding influenza vaccination based on local data
  • Behavioral: National educational information
    • Adult patients in this arm receive educational information regarding influenza vaccination based on national data

Arms, Groups and Cohorts

  • Experimental: Local educational
    • Adult patients in this arm receive educational information regarding influenza vaccination based on local data
  • Experimental: National educational
    • Adult patients in this arm receive educational information regarding influenza vaccination based on national data
  • No Intervention: Usual care
    • No educational information other than provided as usual care by health care providers

Clinical Trial Outcome Measures

Primary Measures

  • Number of participants who receive influenza vaccination on day of intervention
    • Time Frame: Day 0
    • Receipt of influenza vaccination on the day of the educational intervention

Secondary Measures

  • Number of participants who receive Influenza vaccination by the end of the influenza vaccine season
    • Time Frame: Up to 7 months
    • Receipt of influenza vaccination by April 2017

Participating in This Clinical Trial

Inclusion Criteria

  • visit to study site at time of intervention

Exclusion Criteria

  • prior receipt of influenza vaccine that season

Gender Eligibility: Male

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Columbia University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Melissa Stockwell, Associate Professor of Pediatrics and Population and Family Health – Columbia University
  • Overall Official(s)
    • Melissa Stockwell, MD MPH, Principal Investigator, Columbia University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.